1. Home
  2. SGHT vs BYM Comparison

SGHT vs BYM Comparison

Compare SGHT & BYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGHT
  • BYM
  • Stock Information
  • Founded
  • SGHT 2011
  • BYM 2002
  • Country
  • SGHT United States
  • BYM United States
  • Employees
  • SGHT N/A
  • BYM N/A
  • Industry
  • SGHT Medical Specialities
  • BYM Investment Managers
  • Sector
  • SGHT Health Care
  • BYM Finance
  • Exchange
  • SGHT Nasdaq
  • BYM Nasdaq
  • Market Cap
  • SGHT 304.4M
  • BYM 279.5M
  • IPO Year
  • SGHT 2021
  • BYM N/A
  • Fundamental
  • Price
  • SGHT $3.61
  • BYM $10.77
  • Analyst Decision
  • SGHT Buy
  • BYM
  • Analyst Count
  • SGHT 7
  • BYM 0
  • Target Price
  • SGHT $6.27
  • BYM N/A
  • AVG Volume (30 Days)
  • SGHT 206.9K
  • BYM 60.2K
  • Earning Date
  • SGHT 11-07-2024
  • BYM 01-01-0001
  • Dividend Yield
  • SGHT N/A
  • BYM 4.49%
  • EPS Growth
  • SGHT N/A
  • BYM N/A
  • EPS
  • SGHT N/A
  • BYM N/A
  • Revenue
  • SGHT $79,543,000.00
  • BYM N/A
  • Revenue This Year
  • SGHT $2.13
  • BYM N/A
  • Revenue Next Year
  • SGHT $7.99
  • BYM N/A
  • P/E Ratio
  • SGHT N/A
  • BYM N/A
  • Revenue Growth
  • SGHT N/A
  • BYM N/A
  • 52 Week Low
  • SGHT $3.30
  • BYM $9.30
  • 52 Week High
  • SGHT $8.45
  • BYM $11.77
  • Technical
  • Relative Strength Index (RSI)
  • SGHT 41.47
  • BYM 19.67
  • Support Level
  • SGHT $3.45
  • BYM $11.60
  • Resistance Level
  • SGHT $3.64
  • BYM $11.70
  • Average True Range (ATR)
  • SGHT 0.19
  • BYM 0.14
  • MACD
  • SGHT 0.03
  • BYM -0.08
  • Stochastic Oscillator
  • SGHT 38.04
  • BYM 9.35

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.

About BYM Blackrock Municipal Income Quality Trust of Beneficial Interest

Blackrock Municipal Income Quality Trust is a closed-end municipal bond fund. Its investment objective is to provide current income exempt from U.S. federal income taxes, including the alternative minimum tax. The trust invests in various sectors such as transportation, utilities, health, education, corporate, housing, and others.

Share on Social Networks: